3D Bioprinting Market Share and Growth For Business Development 2021 to 2025 - Organovo Holdings Inc., Allevi Inc., Cellink, Aspect Biosystems Ltd.

Global 3D Bioprinting Market Size and Forecast to 2021 – 2025 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data. The research analysts provide a detailed description of the value chain and its distributor analysis. This Market study provides comprehend 3D Bioprinting data that enhances the understanding, scope, and application of this report.

The global 3D bioprinting market is expected to grow from $771.41 million in 2020 to $933.91 million in 2021 at a compound annual growth rate (CAGR) of 21.1%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $1,899.37 million in 2025 at a CAGR of 19.4%.

Click here to get a free sample copy of the latest research on 3D Bioprinting market (Flat 25% off):

https://www.marketinsightsreports.com/reports/11103735680/3d-bioprinting-global-market-report-2021-covid-19-implications-and-growth-including-1-by-component-3d-bioprinters-bioinks-2-by-material-living-cells-hydrogels-extracellular-matrices-others-3-by-application-research-applications-clinical-application-others-4-by-end-user-research-organization-and-academic-institutes-biopharmaceuticals-companies-hospitals-others-covering-organovo-holdings-inc-allevi-inc-cellink-aspect-biosystems-ltd-3d-systems-corporation/inquiry?Mode=KD       

The study includes market share analysis and profiles of players such as Organovo Holdings Inc., Allevi Inc., Cellink, Aspect Biosystems Ltd., 3D Systems Corporation, Cyfuse Biomedical KK, Envisiontec Inc., Poietis, TeVido BioDevices, Nano3D Biosciences Inc., Digilab Inc., RegenHU, GeSIM GmbH, Advanced Solutions Life Sciences LLC, Regenovo Biotechnology Co. Ltd., Regemat 3D S.L., Bio3D Technologies, Stratasys Ltd, ROKIT Healthcare, Inventia Life Science PTY LTD, Vivax Bio LLC, GE Healthcare, and 3D Biotek.

Market Overview:

The 3D bioprinting market consists of sales of 3D bioprinting products by entities (organizations, sole traders, and partnerships) that are engaged in manufacturing and utilizing 3D printing to produce biomedical parts that imitate natural tissue characteristics. 3D Bioprinting is a type of additive manufacturing that prints live structures layer by layer, mimicking the behavior of actual living systems, using cells and other biocompatible materials like inks, also known as bio-inks. 3D bioprinting materials are mainly used in connection with drug research and most recently as cell scaffolds to help repair damaged ligaments and joints.

The main types of components in 3D bioprinting are 3D bioprinters and bio-inks. 3D bioprinters use three-dimensional technology in combination with biocompatible materials to replicate body parts. It is used for bioprinting of tissue, bone, organs, blood vessels tissue, and biomedical parts. The different types of materials include living cells, hydrogels, extracellular matrices, and others. 3D bioprinting is used in research applications, clinical applications, others and implemented in several verticals such as research organizations and academic institutes, biopharmaceuticals companies, hospitals, others.

Rising governments and private funding to support 3D bioprinting research activities are expected to drive the growth of the 3D bioprinting market in the forecast period. 3D bioprinting is increasing applications in healthcare attracted funding from government and private organizations. This funding provides financial and technical assistance across different development phases of 3D bioprinting techniques. For instance, in May 2021, Readily3d SA, a Switzerland-based bioprinting company, received funding of $600,000 from the European Union to develop a living miniature model of the pancreas using its Tomolite 3D bioprinting technique. The Australian Minister for Health funded Curtin University $737,690 in June 2020 to develop and optimize 3D technology for bioprinting skin tissue directly onto model wounds as a prelude to human skin restoration. Furthermore, in January 2020, Aspect Biosystems, a Canada-based 3D bioprinting technology company received a $20 million funding in Series A financing round to advance its technology for 3D bioprinting human tissue which was led by venture capital firm Radical Ventures, Pangaea Ventures, Pallasite Ventures, and Rhino Ventures. Thus, increasing the availability of funding will boost the 3D bioprinting market.

Industry News:

In May 2021, 3D Systems, a US-based company engaged in offering 3D bioprinting technology announced the acquisition of Allevi Inc. for an undisclosed amount. Through this acquisition, 3D Systems plans to utilize Allevi’s expertise to develop applications in the future for the development of human organs in the long term and become a market leader in bioprinting. Allevi Inc. is a US-based company that manufactures 3D bioprinters and bio-inks which are used by researchers.

Market Scope:

1) By Component: 3D Bioprinters; Bioinks
2) By Material: Living Cells; Hydrogels; Extracellular Matrices; Others
3) By Application: Research Applications; Clinical Application; Others
4) By End User: Research Organization And Academic Institutes; Biopharmaceuticals Companies; Hospitals; Others

Browse the report description and TOC:

https://www.marketinsightsreports.com/reports/11103735680/3d-bioprinting-global-market-report-2021-covid-19-implications-and-growth-including-1-by-component-3d-bioprinters-bioinks-2-by-material-living-cells-hydrogels-extracellular-matrices-others-3-by-application-research-applications-clinical-application-others-4-by-end-user-research-organization-and-academic-institutes-biopharmaceuticals-companies-hospitals-others-covering-organovo-holdings-inc-allevi-inc-cellink-aspect-biosystems-ltd-3d-systems-corporation?Mode=KD       

North America was the largest region in the 3D bioprinting market in 2020. The Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the 3D Bioprinting market.

The study objectives of this report are:

To study and analyze the global 3D Bioprinting size (value and volume) by the company, key regions/countries, products and application, history data from 2020 to 2023, and forecast to 2024.
To understand the structure of 3D Bioprinting by identifying its various sub-segments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global 3D Bioprinting manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis, and development plans in the next few years.
To analyze the 3D Bioprinting with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of 3D Bioprinting submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Major Points Covered in Table of Contents:

– Overview of 3D Bioprinting Market
– Global Market Status and Forecast by Regions
– Global Market Status and Forecast by Types
– Global Market Status and Forecast by Downstream Industry
– Market Driving Factor Analysis
– Market Competition Status by Major Manufacturers
– Major Manufacturers Introduction and Market Data
– Upstream and Downstream Market Analysis
– Cost and Gross Margin Analysis
– Marketing Status Analysis
– Market Report Conclusion
– Research Methodology and Reference

Purchase full Report@:

https://www.marketinsightsreports.com/report/purchase/11103735680?mode=su?Mode=KD       

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

This release was published on openPR.